Yoshimura R, Chargui J, Aitouche A, Veyron P, Touraine J L
Unit of Transplantation and Clinical Immunology, Claude Bernard University and INSERM U80, Pavillon P, Hôpital E Herriot, Lyon, France.
Transplantation. 2000 Apr 15;69(7):1452-7. doi: 10.1097/00007890-200004150-00041.
Second-set rejection is generally regarded as a phenomenon mainly mediated by humoral cytotoxic antibodies, although a few discordant data have been presented. In the reported experiments, we have taken advantage of the absence of production of specific cytotoxic alloantibodies contrasting with the normal development of transplantation cellular immunity, in two murine models: chimeric mice and RAG mice.
Chimeras (BALB/c-->CBA) were obtained by transplantation of 2x10(7) fetal liver cells from BALB/c (H-2d) mice to lethally irradiated CBA (H-2k) mice. After hyperimmunization with third-party C57/ BL6 (B6) (H-2b) skin transplants and with injections of 2x10(7) B6 spleen cells, antibody production, and skin graft survival were analyzed. To identify further the factors or cells responsible for accelerated rejection of B6 skin transplants in hyperimmunized chimeras, transfer experiments were carried out involving the injection of serum, whole spleen cells, spleen T cells, spleen CD8+ T cells or spleen CD4+ T cells from chimeras into BALB/c mice that had received 6 Gy irradiation. The recipient mice were then grafted with B6 skin. Similarly, the immunodeficient RAG mice were used to construct a model of recipient animals with anti-H-2d hyperimmunized B6 T cells in the total absence of antibody.
In chimeras, anti-B6 cytotoxic antibodies were not detectable in any of hyperimmunized chimeric mice, yet accelerated rejection of B6 skin transplant occurred: a graft survival of 8.6+/-0.5 days (d), comparable to 8.9+/-0.8 d survival in CBA control mice subjected to the same hyperimmunization procedure, and significantly shorter than that in nonhyperimmunized (BALB/c-->CBA) chimeras (11.6+/-0.5 d) or in non-hyperimmunized CBA control mice (12.1+/-0.6 d). High titers of anti-B6 cytotoxic antibodies were present in the serum of hyperimmunized CBA control mice. In transfer experiments, the graft survival was over 14 d in mice treated with irradiation alone, with irradiation + serum or with irradiation + CD4+ T cells. It was significantly shorter in mice treated with irradiation + whole spleen cells, with irradiation + T cells or with irradiation + CD8+ T cells (8.9+/-0.8 d). Similarly, in immunodeficient RAG mice, reconstitution of the T cell compartment with T cells from hyperimmunized B6 mice led to accelerated rejection of BALB/c skin allografts (11.4+/-1.1 d vs. 18.8+/-0.8 d when T cells were provided by nonimmunized mice). In a second transfer of cells from these reconstituted RAG mice into naive RAG mice, CD8+ T cells were shown to induce accelerated rejection of skin allografts (12.0+/-0.6 d) whereas CD4+ T cells were much less efficient (16.5+/-0.1 d).
These data indicate that T cells, and especially the CD8+ subset, can be responsible for second-set rejection in the absence of anti-donor antibodies in chimeric and RAG mouse models. These sensitized CD8+ T cells are also likely to play an important role in normal mice, in addition to that of cytotoxic antibodies.
尽管已有一些不一致的数据,但二次排斥反应通常被认为是一种主要由体液细胞毒性抗体介导的现象。在已报道的实验中,我们利用了两种小鼠模型(嵌合小鼠和RAG小鼠)中特异性细胞毒性同种异体抗体不产生,而移植细胞免疫正常发育的情况。
通过将2×10⁷个来自BALB/c(H-2d)小鼠的胎肝细胞移植到经致死性照射的CBA(H-2k)小鼠中获得嵌合体(BALB/c→CBA)。在用第三方C57/BL6(B6)(H-2b)皮肤移植进行超免疫并注射2×10⁷个B6脾细胞后,分析抗体产生和皮肤移植存活情况。为了进一步确定导致超免疫嵌合体中B6皮肤移植加速排斥的因素或细胞,进行了转移实验,即将来自嵌合体的血清、全脾细胞、脾T细胞、脾CD8⁺T细胞或脾CD4⁺T细胞注射到接受6 Gy照射的BALB/c小鼠中。然后将受体小鼠移植B6皮肤。同样,免疫缺陷的RAG小鼠被用于构建在完全没有抗体的情况下用抗H-2d超免疫的B6 T细胞的受体动物模型。
在嵌合体中,任何超免疫的嵌合小鼠中均未检测到抗B6细胞毒性抗体,但B6皮肤移植出现了加速排斥:移植存活时间为8.6±0.5天(d),与接受相同超免疫程序的CBA对照小鼠的8.9±0.8 d存活时间相当,且显著短于未超免疫的(BALB/c→CBA)嵌合体(11.6±0.5 d)或未超免疫的CBA对照小鼠(12.1±0.6 d)。超免疫的CBA对照小鼠血清中存在高滴度的抗B6细胞毒性抗体。在转移实验中,单独接受照射、接受照射+血清或接受照射+CD4⁺T细胞治疗的小鼠移植存活时间超过14 d。接受照射+全脾细胞、照射+T细胞或照射+CD8⁺T细胞治疗的小鼠移植存活时间显著缩短(8.9±0.8 d)。同样,在免疫缺陷的RAG小鼠中,用来自超免疫B6小鼠的T细胞重建T细胞区室导致BALB/c皮肤同种异体移植加速排斥(11.4±1.1 d,而由未免疫小鼠提供T细胞时为18.8±0.8 d)。在将这些重建的RAG小鼠的细胞第二次转移到未接触过抗原的RAG小鼠中时,CD8⁺T细胞显示可诱导皮肤同种异体移植加速排斥(12.0±0.6 d),而CD4⁺T细胞的效率则低得多(16.5±0.1 d)。
这些数据表明,在嵌合和RAG小鼠模型中,T细胞,尤其是CD8⁺亚群,在没有抗供体抗体的情况下可导致二次排斥反应。这些致敏的CD8⁺T细胞除了细胞毒性抗体的作用外,在正常小鼠中也可能起重要作用。